Clinical Trials Browser

Phase 3 × Multiple Myeloma × liposomal doxorubicin × Clear all

NCT00097981 2017-04-07

A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma

Phase 3 Completed

225 enrolled 14 charts

Multiple Myeloma

NCT00103506 2015-10-19

Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma

Phase 3 Completed

646 enrolled 10 charts

Multiple Myeloma